会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Amorphous medicinal fine particles produced by pulsed laser ablation in liquid and the production method thereof
    • 液态脉冲激光烧蚀制备的无定形药用细粒及其制备方法
    • US09463243B2
    • 2016-10-11
    • US13765769
    • 2013-02-13
    • Yuki IchikawaAndrius Marcinkevicus
    • Yuki IchikawaAndrius Marcinkevicus
    • A61K9/00A61K41/00A61J3/02A61K9/50A61K9/51
    • A61K41/00A61J3/02A61K9/50A61K9/51Y10T428/2982
    • The present disclosure is directed to an in-liquid laser-based method for fabricating a solution of fine particles of amorphous solid medicinal compounds, a solution of fine particles of amorphous medicinal agents made with the method, and fine particles made with the method. By using a target solidified via a phase transition process to covert an initial crystalline structure into an amorphous solid, technical difficulties with handling a hydraulically-pressed target are overcome. The laser-based ablation process produces amorphous solid medicinal compound fine particles, which improves the bioavailability and solubility of the medicinal compound. The improvement results from a combination of: disordered crystalline structure and enlarged relative surface area by particle size reduction. The laser based method may be carried out with ultrashort pulsed laser systems, or with UV nanosecond lasers. Results obtained with an ultrashort near IR laser and a UV nanosecond laser show formation of amorphous solid curcumin fine particles.
    • 本公开涉及一种用于制造无定形固体药物化合物的细颗粒溶液的液体内基于激光的方法,用该方法制备的非晶医药的微粒溶液和用该方法制备的微粒。 通过使用通过相变过程固化的靶将初始晶体结构转变为无定形固体,克服了处理液压压制靶的技术困难。 基于激光的消融过程产生无定形固体药物复合细颗粒,其改善药物化合物的生物利用度和溶解度。 通过以下组合的改进结果:无序的结晶结构和通过粒径减小扩大的相对表面积。 基于激光的方法可以用超短脉冲激光系统或UV纳秒激光器进行。 用超短距离近红外激光和UV纳秒激光显示的结果显示无定形固体姜黄素细颗粒的形成。
    • 8. 发明申请
    • Amorphous Medicinal Fine Particles Produced By Pulsed Laser Ablation In Liquid And The Production Method Thereof
    • 液体中脉冲激光烧蚀产生的无定形药用微粒及其制备方法
    • US20130209523A1
    • 2013-08-15
    • US13765769
    • 2013-02-13
    • Yuki IchikawaAndrius Marcinkevicus
    • Yuki IchikawaAndrius Marcinkevicus
    • A61K41/00A61J3/02
    • A61K41/00A61J3/02A61K9/50A61K9/51Y10T428/2982
    • The present disclosure is directed to an in-liquid laser-based method for fabricating a solution of fine particles of amorphous solid medicinal compounds, a solution of fine particles of amorphous medicinal agents made with the method, and fine particles made with the method. By using a target solidified via a phase transition process to covert an initial crystalline structure into an amorphous solid, technical difficulties with handling a hydraulically-pressed target are overcome. The laser-based ablation process produces amorphous solid medicinal compound fine particles, which improves the bioavailability and solubility of the medicinal compound. The improvement results from a combination of: disordered crystalline structure and enlarged relative surface area by particle size reduction. The laser based method may be carried out with ultrashort pulsed laser systems, or with UV nanosecond lasers. Results obtained with an ultrashort near IR laser and a UV nanosecond laser show formation of amorphous solid curcumin fine particles.
    • 本公开涉及一种用于制造无定形固体药物化合物的微粒溶液的液体内基于激光的方法,用该方法制备的非晶医药的微粒溶液以及用该方法制成的微粒。 通过使用通过相变过程固化的靶将初始晶体结构转变为无定形固体,克服了处理液压压制靶的技术困难。 基于激光的消融过程产生无定形固体药物复合细颗粒,其改善药物化合物的生物利用度和溶解度。 通过以下组合的改进结果:无序的结晶结构和通过粒径减小扩大的相对表面积。 基于激光的方法可以用超短脉冲激光系统或UV纳秒激光器进行。 用超短距离近红外激光和UV纳秒激光显示的结果显示无定形固体姜黄素细颗粒的形成。